{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T19:59:20Z","timestamp":1726171160658},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,31]]},"DOI":"10.7759\/cureus.48059","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:02:03Z","timestamp":1698778923000},"source":"Crossref","is-referenced-by-count":2,"title":["Myocarditis in SARS-CoV-2: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Ranel","family":"Thaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra","family":"Derti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Schiavone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai CC","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020, 55:105924. 10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7035e5","article-title":"Association between COVID-19 and myocarditis using hospital-based administrative data - United States, March 2020-January 2021","volume":"70","author":"Boehmer TK","year":"2021","unstructured":"Boehmer TK, Kompaniyets L, Lavery AM, et al.. Association between COVID-19 and myocarditis using hospital-based administrative data - United States, March 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:1228-32. 10.15585\/mmwr.mm7035e5","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7114e1","article-title":"Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination - PCORnet, United States, January 2021-January 2022","volume":"71","author":"Block JP","year":"2022","unstructured":"Block JP, Boehmer TK, Forrest CB, et al.. Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination - PCORnet, United States, January 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:517-23. 10.15585\/mmwr.mm7114e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.951314","article-title":"Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: a systematic review and meta-analysis","volume":"9","author":"Voleti N","year":"2022","unstructured":"Voleti N, Reddy SP, Ssentongo P. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: a systematic review and meta-analysis. Front Cardiovasc Med. 2022, 9:951314. 10.3389\/fcvm.2022.951314","journal-title":"Front Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.5511","article-title":"Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older","volume":"181","author":"Simone A","year":"2021","unstructured":"Simone A, Herald J, Chen A, Gulati N, Shen AY, Lewin B, Lee MS. Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Intern Med. 2021, 181:1668-70. 10.1001\/jamainternmed.2021.5511","journal-title":"JAMA Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone M","year":"2022","unstructured":"Patone M, Mei XW, Handunnetthi L, et al.. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022, 28:410-22. 10.1038\/s41591-021-01630-0","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda N","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, et al.. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021, 385:1078-90. 10.1056\/NEJMoa2110475","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2499","article-title":"Features of inflammatory heart reactions following mRNA COVID-19 vaccination at a global level","volume":"111","author":"Chouchana L","year":"2022","unstructured":"Chouchana L, Blet A, Al-Khalaf M, et al.. Features of inflammatory heart reactions following mRNA COVID-19 vaccination at a global level. Clin Pharmacol Ther. 2022, 111:605-13. 10.1002\/cpt.2499","journal-title":"Clin Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31401-5","article-title":"Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines","volume":"13","author":"Le Vu S","year":"2022","unstructured":"Le Vu S, Bertrand M, Jabagi MJ, et al.. Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines. Nat Commun. 2022, 13:3633. 10.1038\/s41467-022-31401-5","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050744","article-title":"Adverse events and safety profile of the COVID-19 vaccines in adolescents: safety monitoring for adverse events using real-world data","volume":"10","author":"Lee CW","year":"2022","unstructured":"Lee CW, Sa S, Hong M, Kim J, Shim SR, Han HW. Adverse events and safety profile of the COVID-19 vaccines in adolescents: safety monitoring for adverse events using real-world data. Vaccines (Basel). 2022, 10:744. 10.3390\/vaccines10050744","journal-title":"Vaccines (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie Y","year":"2022","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022, 28:583-90. 10.1038\/s41591-022-01689-3","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101619","article-title":"Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks","volume":"53","author":"Wang W","year":"2022","unstructured":"Wang W, Wang CY, Wang SI, Wei JC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022, 53:101619. 10.1016\/j.eclinm.2022.101619","journal-title":"EClinicalMedicine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201686","article-title":"Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study","volume":"193","author":"Murk W","year":"2021","unstructured":"Murk W, Gierada M, Fralick M, Weckstein A, Klesh R, Rassen JA. Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study. CMAJ. 2021, 193:E10-8. 10.1503\/cmaj.201686","journal-title":"CMAJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2065","article-title":"Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry","volume":"6","author":"Daniels CJ","year":"2021","unstructured":"Daniels CJ, Rajpal S, Greenshields JT, et al.. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021, 6:1078-87. 10.1001\/jamacardio.2021.2065","journal-title":"JAMA Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068414","article-title":"Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study","volume":"376","author":"Cohen K","year":"2022","unstructured":"Cohen K, Ren S, Heath K, et al.. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022, 376:e068414. 10.1136\/bmj-2021-068414","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00662-w","article-title":"Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms","volume":"19","author":"Heymans S","year":"2022","unstructured":"Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022, 19:75-7. 10.1038\/s41569-021-00662-w","journal-title":"Nat Rev Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.10.001","article-title":"COVID-19 associated myocarditis: a systematic review","volume":"51","author":"Haussner W","year":"2022","unstructured":"Haussner W, DeRosa AP, Haussner D, Tran J, Torres-Lavoro J, Kamler J, Shah K. COVID-19 associated myocarditis: a systematic review. Am J Emerg Med. 2022, 51:150-5. 10.1016\/j.ajem.2021.10.001","journal-title":"Am J Emerg Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11091647","article-title":"Myocardial pathology in COVID-19-associated cardiac injury: a systematic review","volume":"11","author":"Maiese A","year":"2021","unstructured":"Maiese A, Frati P, Del Duca F, et al.. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics (Basel). 2021, 11:1647. 10.3390\/diagnostics11091647","journal-title":"Diagnostics (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-012-9355-6","article-title":"Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease","volume":"18","author":"Basso C","year":"2013","unstructured":"Basso C, Calabrese F, Angelini A, Carturan E, Thiene G. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev. 2013, 18:673-81. 10.1007\/s10741-012-9355-6","journal-title":"Heart Fail Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i7.602","article-title":"Takotsubo cardiomyopathy: pathophysiology, diagnosis and treatment","volume":"6","author":"Komamura K","year":"2014","unstructured":"Komamura K, Fukui M, Iwasaku T, Hirotani S, Masuyama T. Takotsubo cardiomyopathy: pathophysiology, diagnosis and treatment. World J Cardiol. 2014, 6:602-9. 10.4330\/wjc.v6.i7.602","journal-title":"World J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14291","article-title":"Evaluation of autoantibody binding to cardiac tissue in multisystem inflammatory syndrome in children and COVID-19 vaccination-induced myocarditis","volume":"6","author":"Patel H","year":"2023","unstructured":"Patel H, Sintou A, Chowdhury RA, et al.. Evaluation of autoantibody binding to cardiac tissue in multisystem inflammatory syndrome in children and COVID-19 vaccination-induced myocarditis. JAMA Netw Open. 2023, 6:e2314291. 10.1001\/jamanetworkopen.2023.14291","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183625-myocarditis-in-sars-cov-2-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:15Z","timestamp":1707509355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183625-myocarditis-in-sars-cov-2-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.48059","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}